Silicon Valley Bank released its healthcare investments and exits trend report for the first half of 2019. It shows, among other things, oncology losing its first-place status in terms of Series A dollars raised.
Venture capital fundraising this year by biopharma startups is on course to fall behind last year, though it will be above the figure for 2017. But the biggest story may be where that funding is going.
Silicon Valley Bank released its 2019 midyear report, “Trends in Healthcare Investments and Exits 2019,” on Thursday. So far, healthcare companies have raised $5.8 billion in the first half of this year, compared with $9.6 billion for all of 2018 and $9.1 billion in 2017.
But one of the most noteworthy trends is that oncology appears to have lost its first-place status in terms of Series A dollars raised. Although oncology saw the largest number of deals by indication, with 21 Series A rounds, oncology companies raised $483 million. By contrast, companies focused on development platforms saw 20 Series A deals valued at $659 million.
“If you go back historically, oncology has dominated venture investing since 2013,” said SVB Managing Director and report author Jon Norris, in a phone interview.
Image Credit: Silicon Valley Bank
News This Week
Each Cyclops had a single eye because, legend has it, the mythical giants traded the other one with the god Hades in return for the ability to see into the future. But Hades tricked [...]
Over 200 molecules have been discovered in space, some (like Buckminsterfullerene) very complex with carbon atoms. Besides being intrinsically interesting, these molecules radiate away heat, helping giant clouds of interstellar material cool and contract [...]
An international team of scientists, led by the University of Manchester, has developed a metal-organic framework, or MOF, material that provides a selective, fully reversible and repeatable capability to capture a toxic air pollutant, [...]
This week Jamilee interviews Robin Farmanfarmaian. She is a professional speaker and entrepreneur, author of "The Patient as CEO" and "The Thought Leader Formula". Robin is the CEO and Co-founder of ArO. From Jamilee's [...]
Silver and titanium nanomaterials present in wastewater may have toxic effects on crustaceans and fish cells
You may not always think about it when you do your laundry or flush the toilet; but whatever you eat, wear or apply on your skin ends up in wastewater and eventually reaches the [...]
Boston University researchers have developed a new, "intelligent" metamaterial – which costs less than ten dollars to build – that could revolutionize magnetic resonance imaging (MRI), making the entire MRI process faster, safer, and [...]
We can directly see the hidden world of atoms thanks to electron microscopes, first developed in the 1930s. Today, electron microscopes, which use beams of electrons to illuminate and magnify a sample, have become [...]
In her inaugural podcast, Jamilee interviews Frank Boehm of NanoApps Medical Inc and NanoApps Athletics Inc. From Jamilee's podcast: Welcome to the first episode of "In a Click". On todays show I chat with [...]
“We’ll have nanobots that… connect our neocortex to a synthetic neocortex in the cloud. Our thinking will be a…. biological and non-biological hybrid.” Ray Kurzweil, TED 2014 UPDATE - October 30 2019 Since [...]
We humans have evolved a rich repertoire of communication, from gesture to sophisticated languages. All of these forms of communication link otherwise separate individuals in such a way that they can share and express [...]
Ultrasensitive nanoscale optical probes have been created by scientists from UC Santa Cruz, to observe the bioelectric activity of neurons and other excitable cells. This innovative readout technology could allow researchers to analyze how [...]
Advances made during recent clinical trials mean that those suffering from celiac disease may soon be able to reintroduce gluten back into their diet. This breakthrough is down to a progressive new treatment that [...]
A new way of editing the code of life could correct 89% of the errors in DNA that cause disease, say US scientists. The technology, called prime editing, has been described as a "genetic [...]